Luke Lambourne (@LukeLambs) profile picture
Boston
Joined March 2014
Photo by Luke Lambourne (@LukeLambs)Photo by Luke Lambourne (@LukeLambs)Photo by Luke Lambourne (@LukeLambs)Photo by Luke Lambourne (@LukeLambs)Photo by Luke Lambourne (@LukeLambs)Photo by Luke Lambourne (@LukeLambs)Photo by Luke Lambourne (@LukeLambs)Photo by Luke Lambourne (@LukeLambs)Photo by Luke Lambourne (@LukeLambs)Photo by Luke Lambourne (@LukeLambs)
Luke Lambourne retweeted
Cysteine is essential for life, and toxic in excess. Cells keep its abundance tightly controlled despite constant inputs from diet and metabolism. How cells directly sense cysteine and prevent its accumulation has been a longstanding mystery that our new paper addresses:
6
22
1
131
9,883
Excited to share our latest paper led by Renata Goncalves @RenataG81952725: CoQ imbalance drives reverse electron transport to disrupt liver metabolism. nature.com/articles/s41586-0… We uncover how altered CoQ redox balance triggers RET and rewires hepatic metabolism to offer critical insights into a decades old question. Meticulously mapping each one of the 11 sites of the mitochondrial electron transport chain in the liver showed site IQ as the sole source of excess mitochondrial ROS, produced via reverse electron transport. This defect is driven by CoQ imbalance in obesity, disrupts glucose metabolism. These findings may have implications for many diseases and open up new treatment possibilities where broad antioxidants have failed to generate therapeutic benefit. Our findings may also offer a potential mechanism and solution for the increased diabetes risk seen in a small fraction of statin users. Huge congratulations to Renata Goncalves @RenataG81952725 for leading this work and for her immense dedication and patience to bring it to a conclusion. Congratulations to all contributors from the @hotamisligil lab and our amazing collaborators Isabel Graupera @igraupe and Shawn Burgess @Isotopomer Curious? The 93-page-long peer review file is full of useful information and insightful discussions.
13
30
142
13,891
Luke Lambourne retweeted
Using idc rates to optimize research deserves study and modification. But the approach just taken was designed not to improve the process, but to harm institutions, researchers and biomed research. Many supporting this action seem ignorant about the US biomed research ecosystem.
This approach to suddenly cutting @NIH grant indirect costs will cause chaos and harm biomedical research and researchers in hospitals, schools and institutes nationwide. A sane government would never do this.
11
17
2
90
21,141
Luke Lambourne retweeted
Let’s play a little game. Let’s say that you’re the CSO at a cancer pharma company, and you have to choose a target to go after. Here’s a gene – high expression is associated with poor prognosis in brain cancer. Looks like a good candidate for an inhibitor right?
67
1,435
439
3,399
Luke Lambourne retweeted
Prospective power analysis is hilarious because your replace an arbitrary guess of sample size with an arbitrary guess of the effect size you’ve yet to measure, do a touch of arithmetic, and suddenly it’s considered rigorous
26
50
12
499
153,803
Luke Lambourne retweeted
Our latest work on developing a potent and specific tool for activating or repressing endogenous splicing events is out! authors.elsevier.com/c/1jJci…
Graduate student Jack Li's work out in Molecular Cell now: By conducting a screen of 341 splicing factors, Jack identified RBM25 coupled to dCasRx as a superior tool to boost inclusion of endogenous exons /1
5
26
108
11,635
Thank you Jan for the intensive testing and interesting findings! For the templates, it is the same cutoff as mentioned in the paper, i.e. 2021-09-30. We will add this to the Server FAQ for clarity and will let users know if we change this date
3
5
2
18
28,868
Luke Lambourne retweeted
rdcu.be/dHF8a Happy to share our latest work on hepatic ER and mitochondria structure. We analyzed ER & mitochondria shape and their interactions across liver zonation, in fasting/feeding cycles and in obesity! Grateful for everyone involved! @apsarruda @ghotamis Shan & Song @refikanadol @BerkeleyMetBio @UCBerkeley @NatureAtCal @Harvard @HHMIJanelia @Yale
6
20
2
103
14,644
excited to share the first story from my postdoc today!! we profiled hundreds of transcription factor (TF) isoforms & found that two-thirds of alternative TF isos differ from their cognate reference iso in at least 1 key molecular activity biorxiv.org/content/10.1101/…
10
55
8
240
42,913
Alternative TF isoforms often had different localization and condensate formation properties from the corresponding reference isoform
1
3
113
Based on these widespread differences in molecular functions, alternative isoforms of TFs form a crucial, but neglected, layer in the regulation of gene expression. Improving knowledge of this layer will be key to future progress in understanding cellular function and dysfunction
1
2
88
Changes in binding to cofactors and signaling proteins were associated with changes in activation
1
2
66
And, once you account for sequence identity, isoforms of the same gene are as different as paralogous genes
1
2
59
Of all protein-partners, it was the obligate dimerizing of TFs that was most preserved across different isoforms (e.g. bHLH-bHLH, bZIP-bZIP etc.) suggesting a need to preserve those for these alternative isoforms to function
1
2
65
I'm excited to share our preprint on the molecular properties of transcription factor protein isoforms: biorxiv.org/content/10.1101/…
4
3
17
1,435
We found most alternative isoforms differed from the reference isoform of the same gene. Those differences are really challenging to predict from sequence features, e.g. differences in disordered regions far from the DNA-binding domain frequently affected DNA-binding
1
2
52
So we generated a clone collection of 700 isoforms of 250 TF genes and systematically tested their DNA-binding, protein-protein interactions, transcriptional activation, and localization/condensate formation.
1
2
68